AIM HIGHer Study

This study will assess the CCM® therapy delivery system of the Optimizer® Smart Mini device for heart failure subjects identified with a higher ejection fraction.


You may be eligible for the study if you have been diagnosed with both the following:

  • Symptomatic heart failure
  • Have a left ventricular ejection fraction (LVEF or EF) that is 40 – 60%

Full details and contact information on the study and participating hospitals will be updated regularly.

Research Institutions and Investigators

If you are interested in participating in the AIM HIGHer study, contact the Impulse Dynamics clinical team by clicking on the link below.